Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Aug 01, 2009 (Vol. 29, No. 14)

CellDeath.de

URL:www.celldeath.de/mainfram.htm
  • Great links
  • Lacking content in some areas

Whether you pronounce it “AY-POP-TOE-SIS” or “AP-O-TOE-SIS,” scientists with a morbid interest in cell death will enjoy CellDeath.de, an initiative started and maintained by Ph.D. students. The site is clearly a work-in-progress, as evidenced by some blank pages and outdated conference dates/publications. However, the scaffolding is in place to make this site a hub for apoptosis research. Currently, there is an expansive encyclopedia (or rather, an “apoptopedia”) of apoptosis-related terms, as well as a collection of protocols. The links page features not only apoptosis-related sites, but also scientific glossaries and a very useful list of scientific databases. Additionally, there is an incomplete list of labs studying apoptosis, to which any cell death researcher can add him/herself.  This site has great potential, but it is dependent on users contributing information—so get the word out!

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »